Wu Chien-Chih, Tai Chih-Hsun, Liao Wen-You, Wang Chi-Chuan, Kuo Ching-Hua, Lin Shu-Wen, Ku Shih-Chi
Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Infect Drug Resist. 2019 Aug 16;12:2531-2541. doi: 10.2147/IDR.S213183. eCollection 2019.
Augmented renal clearance (ARC) is common in critically ill patients and could result in subtherapeutic antibiotic concentration. However, data in the Asian population are still lacking. The aim of this study was to explore the incidence and risk factors of ARC and its effect on β-lactam pharmacokinetics/pharmacodynamics (PK/PD) in Asian populations admitted to a medical ICU. In addition, we evaluated the appropriateness of using three estimated glomerular filtration (eGFR) formulas [Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)] as screening tools.
We measured 2-, 8-, and 24-hr creatinine clearance (CL) and calculated eGFR by using three formulas for each. ARC was defined as CL >130 mL/min/1.73 m. Concentrations at the mid-dosing interval and prior to the next dose were collected if patients received the β-lactam antibiotic of piperacillin/tazobactam, cefepime, and meropenem, to determine the PK/PD index of fT > MIC. Multiple logistic regression analysis was conducted to identify the risk factors for ARC. Pearson correlation coefficient and the Bland and Altman method were applied to assess the accuracy of CL, CL, and eGFR for predicting ARC.
Of 100 patients, 46 (46%) manifested ARC. Younger age (<50 years) and lower Sequential Organ Failure Assessment score increased the likelihood of ARC. ARC resulted in a low chance of achieving 50% fT >4MIC (33% vs 75%, <0.01), 100% fT > MIC (23% vs 69%, <0.01), and 100% fT >4MIC (3% vs 25%, <0.02). CL wielded the best correlation and agreement with CL. eGFR was the most appropriate screening tool, and the optimal cutoff value for detecting ARC was 130.5 mL/min/1.73 m.
ARC is associated with inadequate β-lactam PK/PD target in Asian ICU.
强化肾清除率(ARC)在危重症患者中很常见,可能导致抗生素浓度低于治疗水平。然而,亚洲人群的数据仍然缺乏。本研究的目的是探讨入住内科重症监护病房(ICU)的亚洲人群中ARC的发生率、危险因素及其对β-内酰胺类药物药代动力学/药效学(PK/PD)的影响。此外,我们评估了使用三种估算肾小球滤过率(eGFR)公式[Cockcroft-Gault(CG)公式、肾脏病饮食改良(MDRD)公式和慢性肾脏病流行病学协作组(CKD-EPI)公式]作为筛查工具的适用性。
我们测量了2小时、8小时和24小时的肌酐清除率(CL),并使用三种公式分别计算eGFR。ARC定义为CL>130 mL/min/1.73 m²。如果患者接受哌拉西林/他唑巴坦、头孢吡肟和美罗培南等β-内酰胺类抗生素治疗,则收集给药间隔中期和下次给药前的血药浓度,以确定fT>MIC的PK/PD指数。进行多因素逻辑回归分析以确定ARC的危险因素。应用Pearson相关系数以及Bland和Altman方法评估CL、CL和eGFR预测ARC的准确性。
100例患者中,46例(46%)表现出ARC。年龄较小(<50岁)和序贯器官衰竭评估评分较低会增加ARC的可能性。ARC导致达到50%fT>4MIC的概率较低(33%对75%,P<0.01)、100%fT>MIC的概率较低(23%对69%,P<0.01)以及100%fT>4MIC的概率较低(3%对25%,P<0.02)。CL与CL的相关性和一致性最佳。eGFR是最合适的筛查工具,检测ARC的最佳临界值为130.5 mL/min/1.73 m²。
在亚洲ICU中,ARC与β-内酰胺类药物PK/PD目标未达标有关。